Answers are grounded in this paper and cite their sources.
Bacterial infection remains one of the major causes of morbidity and mortality early after allogeneic hematopoietic cell transplantation (allo-HCT) because of a patient's immunocompromised state requiring use of antibiotic treatments as prophylactic regimens or to treat manifest infections and neutropenic fever (NF). Based on preclinical studies performed in early 1970s indicating the benefit of gut bacterial decontamination in preventing the development of acute graft-versus-host disease (GVHD), Another indication for using empiric antibiotics is to treat NF that occurs in more than 90% of patients. 5 Antibiotics, however, are able to damage the commensal gut microflora to various degrees, depending on the antibiotic class. This becomes of increasing interest as recent studies with advanced DNA sequencing techniques of gutresident microorganisms begin to provide detailed relationships between the gut microbiota and clinical outcomes of allo-HCT, including overall survival (OS), 8 transplant-related mortality (TRM), 9 acute GVHD, 8-12 relapse, 13 and development of bacteremia. Given the emerging evidence that the preserved diversity of gut microbiota is correlated with better clinical outcomes after allo-HCT, 8,9,12 concerns have been raised regarding the practice of GD for prophylaxis as well as the use of broadspectrum antibiotics for NF that target anaerobic bacteria of the gut (anaerobes). n der Waaij et al described the role of the anaerobes in colonization resistance in the 1970s. The article refers to resistance of the host to colonization with a microbial pathogen triggered by the indigenous commensal microflora of the gut. Since then, the anaerobic flora with the major Clostridia and Bacteroidetes genera have been proven repeatedly to prevent long-term colonization by pathogenic bacteria such as Clostridium difficile, Salmonella enterica, or vancomycin-resistant enterococci. 9] Moreover, a small, prospective case cohort study in 15 pediatric allo-HCT patients found an association between bacteria of Clostridia cluster IV and XIVa with anti-inflammatory properties and suppression of GVHD. mportantly, treatment with antibiotics results in loss of bacterial diversity; this loss can affect GVHDrelated outcomes and OS after allo-HCT. Loss of bacterial diversity on day 12 or within 7 days of neutrophil engraftment were associated with increased mortality from GVHD. This emerging knowledge regarding the role of the microbiota (especially the beneficial roles of anaerobes) in the health of allo-HCT patients raises questions as to the practice of bacterial decontamination as well as ideal choices of antibiotics for NF, 23 causing a reappraisal of the manner in which antibiotics are used in allo-HCT.
No takes yet. Share an insight, caveat, or question.
Shono et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: